The cannabis boom continues to rage rampantly, while another major industry, previously inaccessible because of the War on Drugs and research restrictions, is making its way to the forefront.
Psychedelics have spent decades under a Schedule I classification, deeming them to have “high abuse potential, no accepted medical use and a lack of safety even under medical supervision.” The research so far, however, conversely proves these drugs indeed hold the potential to reshape an entire market around mental health and more.
The legislative surge was swift: Denver, Colorado was the first US city in May 2019 to make the personal use and possession of small, noncommercial amounts of psychedelic drugs the lowest law enforcement priority. Oakland and Santa Cruz, California soon followed suit, opening the doors for larger cities, like…
